Takahiro Kogawa

6PUBLICATIONS
70CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 13, 2026
Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancer.

S Kusuhara, T Kogawa, M Shimokawa

|Oct 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.

Thomas Powles, Aarti Bhatia, Barbara Burtness

|May 13, 2025
Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers.

Mohd Mughees, Moises Tacam, Alex W Tan

|Apr 23, 2024
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study.

Aditya Bardia, Ian E Krop, Takahiro Kogawa

|Jun 28, 2023
Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer.

Xuemei Xie, Gaurav B Chauhan, Ramakrishna Edupuganti

Pageof 1